Jeff serves as the President & Chief Executive Officer and a Director of Belharra, which he joined in September 2021 as its first employee. He is an accomplished biotech executive with extensive experience as an operator, director, senior advisor, and outside counsel for a broad range of public and private companies and venture investors. Prior to Belharra, Jeff served as CEO of Ambys Medicines, President of NGM Pharmaceuticals (NASDAQ: NGM), and Senior Vice President, Corporate and Business Development at Theravance Biopharma (NASDAQ: TBPH)). His other executive roles include Chief Business Officer of Satori Pharmaceuticals, Vice President of Business Development and Corporate Strategy for Gloucester Pharmaceuticals prior to its acquisition by Celgene (NASDAQ: CELG), and multiple leadership positions in the business development and legal groups at Genentech. Jeff began his career at Wilson Sonsini, representing clients in the life science and high-tech industries. Jeff serves on the Board of Directors of California Life Sciences. Jeff holds a J.D. from Columbia University School of Law, an M.LITT. from the University of St. Andrews, and a B.A. from Claremont McKenna College.